Author:
Kosmeder Jerome W.,Pezzuto John M.
Reference330 articles.
1. Foulds L. 1969. Neoplastic Development. New York: Academic Press.
2. Morse MA, Stoner GD. 1993. Cancer chemoprevention. Principles and prospects. Carcinogenesis 14:1737–1746.
3. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. 1990. Biomarkers as intermediate endpoints in chemoprevention trials. J Natl Cancer Inst 82:555–560.
4. Kelloff GJ, Sigman CC, Johnson KM, Boone CW, Greenwald P, Crowell JA, Hawk ET, Doody LA. 2000. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epid Bio Prey 9:127–137.
5. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Doody LA. 1994. Surrogate endpoint biomarkers for Phase II cancer chemopreventive trials. J Cell Biochem 19:1–9.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献